Arcturus Therapeutics Holdings

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARCT and other ETFs, options, and stocks.

About ARCT

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. 

CEO
Joseph E. Payne
CEOJoseph E. Payne
Employees
111
Employees111
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2013
Founded2013
Employees
111
Employees111

ARCT Key Statistics

Market cap
320.04M
Market cap320.04M
Price-Earnings ratio
-3.40
Price-Earnings ratio-3.40
Dividend yield
—
Dividend yield—
Average volume
678.43K
Average volume678.43K
High today
$11.42
High today$11.42
Low today
$10.63
Low today$10.63
Open price
$11.03
Open price$11.03
Volume
493.34K
Volume493.34K
52 Week high
$24.17
52 Week high$24.17
52 Week low
$5.50
52 Week low$5.50

Stock Snapshot

With a market cap of 320.04M, Arcturus Therapeutics Holdings(ARCT) trades at $11.15. The stock has a price-to-earnings ratio of -3.40.

As of 2026-10-15, Arcturus Therapeutics Holdings(ARCT) stock has fluctuated between $10.63 and $11.42. The current price stands at $11.15, placing the stock +4.9% above today's low and -2.4% off the high.

The Arcturus Therapeutics Holdings(ARCT)'s current trading volume is 493.34K, compared to an average daily volume of 678.43K.

In the last year, Arcturus Therapeutics Holdings(ARCT) shares hit a 52-week high of $24.17 and a 52-week low of $5.50.

In the last year, Arcturus Therapeutics Holdings(ARCT) shares hit a 52-week high of $24.17 and a 52-week low of $5.50.

ARCT News

Benzinga 2d
Transcript: Arcturus Therapeutics Q2 2026 Earnings Conference Call - Benzinga

...

Transcript: Arcturus Therapeutics Q2 2026 Earnings Conference Call - Benzinga

Analyst ratings

85%

of 13 ratings
Buy
84.6%
Hold
15.4%
Sell
0%

People also own

Based on the portfolios of people who own ARCT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.